Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

HealthLynked (HLYK) Return on Sales (2016 - 2025)

Historic Return on Sales for HealthLynked (HLYK) over the last 10 years, with Q3 2025 value amounting to 1.36%.

  • HealthLynked's Return on Sales rose 14700.0% to 1.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.18%, marking a year-over-year change of 0.0%. This contributed to the annual value of 2.04% for FY2024, which is 24900.0% down from last year.
  • Latest data reveals that HealthLynked reported Return on Sales of 1.36% as of Q3 2025, which was up 14700.0% from 0.74% recorded in Q2 2025.
  • Over the past 5 years, HealthLynked's Return on Sales peaked at 1.92% during Q4 2021, and registered a low of 4.38% during Q1 2021.
  • For the 5-year period, HealthLynked's Return on Sales averaged around 0.64%, with its median value being 0.18% (2022).
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by -39500bps in 2021, then skyrocketed by 42900bps in 2022.
  • HealthLynked's Return on Sales (Quarter) stood at 1.92% in 2021, then crashed by -107bps to 0.14% in 2022, then surged by 100bps to 0.0% in 2023, then plummeted by -7118827bps to 1.99% in 2024, then skyrocketed by 31bps to 1.36% in 2025.
  • Its Return on Sales was 1.36% in Q3 2025, compared to 0.74% in Q2 2025 and 0.8% in Q1 2025.